Of note, a seminal study used chromogenic in situ hybridization (CISH) on a small sample of PC patient samples to analyze gene amplification and showed that ERBB2 amplification levels were directly associated with tumor stage, prostate-specific antigen PSA levels, or a high Gleason score in PC patients. This evidence concerns the gene ERBB2 and neoplasm.